Clinical Trial Update: A Single Ascending Dose Study Investigating the Safety, Pharmacokinetics and Pharmacodynamics of RO6836191 in Healthy Male Volunteers. [Phase 1]

View source ↗

Summary

Phase 1 single ascending dose study evaluating safety, pharmacokinetics and pharmacodynamics of RO6836191 in healthy male volunteers has completed. The trial li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• RO6836191

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Atherosclerosis | Phase 1 | Status: COMPLETED